BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 11406567)

  • 1. Inhibition of epidermal growth factor-induced RhoA translocation and invasion of human pancreatic cancer cells by 3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitors.
    Kusama T; Mukai M; Iwasaki T; Tatsuta M; Matsumoto Y; Akedo H; Nakamura H
    Cancer Res; 2001 Jun; 61(12):4885-91. PubMed ID: 11406567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lovastatin suppresses invasiveness of anaplastic thyroid cancer cells by inhibiting Rho geranylgeranylation and RhoA/ROCK signaling.
    Zhong WB; Liang YC; Wang CY; Chang TC; Lee WS
    Endocr Relat Cancer; 2005 Sep; 12(3):615-29. PubMed ID: 16172195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitors reduce human pancreatic cancer cell invasion and metastasis.
    Kusama T; Mukai M; Iwasaki T; Tatsuta M; Matsumoto Y; Akedo H; Inoue M; Nakamura H
    Gastroenterology; 2002 Feb; 122(2):308-17. PubMed ID: 11832446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of transendothelial migration and invasion of human breast cancer cells by preventing geranylgeranylation of Rho.
    Kusama T; Mukai M; Tatsuta M; Nakamura H; Inoue M
    Int J Oncol; 2006 Jul; 29(1):217-23. PubMed ID: 16773203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of lysophosphatidic acid-induced RhoA activation and tumor cell invasion by 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors.
    Kusama T; Mukai M; Ayaki M; Imamura F; Tatsuta M; Matsumoto Y; Nakamura H; Inoue M
    Int J Oncol; 2003 Oct; 23(4):1173-8. PubMed ID: 12964001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitor, fluvastatin, as a novel agent for prophylaxis of renal cancer metastasis.
    Horiguchi A; Sumitomo M; Asakuma J; Asano T; Asano T; Hayakawa M
    Clin Cancer Res; 2004 Dec; 10(24):8648-55. PubMed ID: 15623649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HMG-CoA reductase inhibitor fluvastatin prevents angiotensin II-induced cardiac hypertrophy via Rho kinase and inhibition of cyclin D1.
    Morikawa-Futamatsu K; Adachi S; Maejima Y; Tamamori-Adachi M; Suzuki J; Kitajima S; Ito H; Isobe M
    Life Sci; 2006 Aug; 79(14):1380-90. PubMed ID: 16712874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors decrease Fas ligand expression and cytotoxicity in activated human T lymphocytes.
    Blanco-Colio LM; Muñoz-García B; Martín-Ventura JL; Lorz C; Díaz C; Hernández G; Egido J
    Circulation; 2003 Sep; 108(12):1506-13. PubMed ID: 12952848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HMG-CoA reductase inhibitors reduce nicotine-induced expression of cellular adhesion molecules in cultured human coronary endothelial cells.
    Cirillo P; Pacileo M; De Rosa S; Calabrò P; Gargiulo A; Angri V; Prevete N; Fiorentino I; Ucci G; Sasso L; Petrillo G; Musto D'Amore S; Chiariello M
    J Vasc Res; 2007; 44(6):460-70. PubMed ID: 17657162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of RhoA activation in the growth and morphology of a murine prostate tumor cell line.
    Ghosh PM; Ghosh-Choudhury N; Moyer ML; Mott GE; Thomas CA; Foster BA; Greenberg NM; Kreisberg JI
    Oncogene; 1999 Jul; 18(28):4120-30. PubMed ID: 10435593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Rho protein in lovastatin-induced breakdown of actin cytoskeleton.
    Koch G; Benz C; Schmidt G; Olenik C; Aktories K
    J Pharmacol Exp Ther; 1997 Nov; 283(2):901-9. PubMed ID: 9353412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue factor induction by aggregated LDL depends on LDL receptor-related protein expression (LRP1) and Rho A translocation in human vascular smooth muscle cells.
    Camino-López S; Llorente-Cortés V; Sendra J; Badimon L
    Cardiovasc Res; 2007 Jan; 73(1):208-16. PubMed ID: 17141748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alendronate inhibits invasion of PC-3 prostate cancer cells by affecting the mevalonate pathway.
    Virtanen SS; Väänänen HK; Härkönen PL; Lakkakorpi PT
    Cancer Res; 2002 May; 62(9):2708-14. PubMed ID: 11980672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HMG-CoA reductase inhibitor simvastatin mitigates VEGF-induced "inside-out" signaling to extracellular matrix by preventing RhoA activation.
    Xu H; Zeng L; Peng H; Chen S; Jones J; Chew TL; Sadeghi MM; Kanwar YS; Danesh FR
    Am J Physiol Renal Physiol; 2006 Nov; 291(5):F995-1004. PubMed ID: 16774905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simvastatin potentiates tumor necrosis factor alpha-mediated apoptosis of human vascular endothelial cells via the inhibition of the geranylgeranylation of RhoA.
    Tang D; Park HJ; Georgescu SP; Sebti SM; Hamilton AD; Galper JB
    Life Sci; 2006 Sep; 79(15):1484-92. PubMed ID: 16740276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple mitogenic pathways in pancreatic cancer cells are blocked by a truncated epidermal growth factor receptor.
    Matsuda K; Idezawa T; You XJ; Kothari NH; Fan H; Korc M
    Cancer Res; 2002 Oct; 62(19):5611-7. PubMed ID: 12359775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lovastatin-induced PC-12 cell differentiation is associated with RhoA/RhoA kinase pathway inactivation.
    Fernández-Hernando C; Suárez Y; Lasunción MA
    Mol Cell Neurosci; 2005 Aug; 29(4):591-602. PubMed ID: 15951198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HMG-CoA reductase inhibitor lovastatin causes reversible cytoskeleton perturbation by RhoA signalling suppression in peritoneal cell line Met5A.
    Suzuki N; Imai A
    J Obstet Gynaecol; 2010 May; 30(4):404-7. PubMed ID: 20455727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HMG CoA reductase inhibition modulates VEGF-induced endothelial cell hyperpermeability by preventing RhoA activation and myosin regulatory light chain phosphorylation.
    Zeng L; Xu H; Chew TL; Eng E; Sadeghi MM; Adler S; Kanwar YS; Danesh FR
    FASEB J; 2005 Nov; 19(13):1845-7. PubMed ID: 16160062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimulatory effects of low-dose 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor fluvastatin on hepatocyte growth factor-induced angiogenesis: involvement of p38 mitogen-activated protein kinase.
    Uruno A; Sugawara A; Kudo M; Satoh F; Saito A; Ito S
    Hypertens Res; 2008 Nov; 31(11):2085-96. PubMed ID: 19098381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.